Prospera Financial Services Inc Repligen Corp Transaction History

Prospera Financial Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$140.68 - $188.02 $46,565 - $62,234	-331 Reduced 74.55%	113 $18,000
Q1 2022 May 04, 2022	BUY	$161.19 - $257.96 $71,568 - $114,534	444 New	444 $84,000
Q4 2020 Feb 12, 2021	SELL	$148.08 - $206.57 $6,811 - $9,502	-46 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$122.51 - $158.27 $856,467 - $1.11 Million	-6,991 Reduced 99.35%	46 $7,000
Q2 2020 Aug 07, 2020	BUY	$94.33 - $140.48 $8,867 - $13,205	94 Added 1.35%	7,037 $870,000
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $589,877 - $757,759	6,943 New	6,943 $670,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.94B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.